Madrigal Pharmaceuticals

Activities: Ingredients Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. ChargePoint invest in a single-use manufacturing facility to expand product line The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
  3. Innovation in generics: increased efficiency through peptide API synthesis expertise Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
  4. Bayer HealthCare and Johns Hopkins University to collaborate on new ophthalmic therapies The partners will work jointly on the discovery and development of innovative drugs for the treatment of serious back-of-the-eye diseases
  5. Berry Global invests to increase production capacity for healthcare products Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Ingredients

Therapeutic: resmetirom for non-alcoholic steatohepatitis

Patients with non-alcoholic steatohepatitis (NASH) have a build-up of fat in the liver with no obvious cause (such as alcohol consumption). It can lead to cirrhosis, liver cancer or liver failure and can also result in cardiovascular disease
Subscribe now